Related Experiment Video
Updated: Feb 26, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.4K
Werner syndrome: a model for sarcopenia due to accelerated aging
Masaya Yamaga1,2, Minoru Takemoto1,3, Mayumi Shoji1,2
1Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, 260-8670, Japan.
Aging
|July 25, 2017
Summary
Werner syndrome (WS) patients exhibit significant muscle loss (sarcopenia) and reduced mobility, even before age 40. This study precisely details body composition changes in WS, highlighting the need for further research into sarcopenia mechanisms and treatments.
Area of Science:
- Gerontology
- Genetics
- Metabolic Diseases
Background:
- Werner syndrome (WS) is a rare genetic disorder characterized by premature aging.
- WS is linked to mutations in the WRN gene, affecting DNA repair.
- Limited data exists on body composition and mobility changes in WS patients.
Purpose of the Study:
- To precisely describe body composition, including muscle and fat mass.
- To evaluate mobility and functional status in individuals with Werner syndrome.
- To investigate age and sex-specific differences in body composition and mobility in WS.
Main Methods:
- Recruited nine Japanese patients with Werner syndrome (WS).
- Assessed body composition using dual-energy X-ray absorptiometry (DXA) and computed tomography (CT).
- Evaluated hand grip strength and mobility via the two-step test, stand-up test, and Geriatric Locomotive Function Scale (GLFS).
Main Results:
- All WS patients met the diagnostic criteria for sarcopenia, indicated by a mean skeletal muscle index (SMI) of 4.0±0.6 kg/m².
- Sarcopenia was observed even in patients younger than 40 years.
- All participants demonstrated decreased mobility and functional capacity.
Conclusions:
- Patients with Werner syndrome experience significant muscle mass loss (sarcopenia) and reduced mobility, regardless of age (even <40 years).
- These findings underscore the profound impact of WS on musculoskeletal health.
- Further research into sarcopenia in WS may reveal novel insights and therapeutic targets for age-related muscle decline.
Related Concept Videos
Aging
894
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
894
The Effect of Aging on Tissues
4.0K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.0K
Mitochondria
21.0K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.0K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K

